Patent intelligence · US
US 11229647
Methods for treating cholestasis
Methods for treating cholestasis
Patent details — US 11229647
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 25, 2022
- Expiration
- Jan 20, 2042
- Applicant
- MIRUM PHARMACEUTICALS, INC.
- Claims
- 13
- CPC classes
- A61K, A61K31/4995, A61K31/554, A61K31/7042
Quick answer
US 11229647 (Methods for treating cholestasis) is held by MIRUM PHARMACEUTICALS, INC.. Status: granted. Granted Jan 25, 2022. Expires Jan 20, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MIRUM PHARMACEUTICALS, INC.
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K31/4995, A61K31/554, A61K31/7042, A61K38/05, A61P
More from MIRUM PHARMACEUTICALS, INC.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 11229647?
US 11229647 (Methods for treating cholestasis) is held by MIRUM PHARMACEUTICALS, INC.. Status: granted. Granted Jan 25, 2022. Expires Jan 20, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11229647?
MIRUM PHARMACEUTICALS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 11229647 expire?
Our index shows an expiration date of Jan 20, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.